precision medicine

R&D

From precision medicine to precision skin health: Verily and...

Verily, an Alphabet precision health tech company, and L’Oréal, a leading household name in beauty, have announced the launch of the ‘My Skin & Hair Journey’ – a multi-year study to ena

Oncology

Gaps in breast cancer care in Europe and the importance of g...

Breast cancer places a pressing burden on patients, physicians, and healthcare systems.

R&D

Trials and tribulations of drug development

What does it take to establish new treatments for rare diseases?

R&D

JP Morgan 2023 – Joe Spinelli

In this final (honorary) sit-down from the JP Morgan Chase Healthcare Conference in San Francisco last month, pharmaphorum editor-in-chief Jonah Comstock chats virtually with Joe Spinelli, SVP prod

News

Sanofi, CytoReason expand AI deal into IBD

Tech company CytoReason has announced it has signed a multi-year, multimillion dollar deal with Sanofi to deliver artificial intelligence (AI) for drug discovery and development in the fiel

Oncology